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Coupling of a viral K+-channel with a glutamate-
binding-domain highlights the modular design of
ionotropic glutamate-receptors
Michael Schönrock1, Gerhard Thiel2 & Bodo Laube1
Ionotropic glutamate receptors (iGluRs) mediate excitatory neuronal signaling in the mam-
malian CNS. These receptors are critically involved in diverse physiological processes;
including learning and memory formation, as well as neuronal damage associated with
neurological diseases. Based on partial sequence and structural similarities, these complex
cation-permeable iGluRs are thought to descend from simple bacterial proteins emerging
from a fusion of a substrate binding protein (SBP) and an inverted potassium (K+)-channel.
Here, we fuse the pore module of the viral K+-channel KcvATCV-1 to the isolated glutamate-
binding domain of the mammalian iGluR subunit GluA1 which is structural homolog to SBPs.
The resulting chimera (GluATCV*) is functional and displays the ligand recognition char-
acteristics of GluA1 and the K+-selectivity of KcvATCV-1. These results are consistent with a
conserved activation mechanism between a glutamate-binding domain and the pore-module
of a K+-channel and support the expected phylogenetic link between the two protein families.
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Conversion of a chemical to an electrical signal is a hallmarkof neurons in the central nervous system (CNS). Thisprocess is mediated by different families of ligand-gated
ion-channels, membrane-spanning proteins that open upon
recognition of a speciﬁc neurotransmitter. In particular, gating of
cation-permeable receptors by the amino acid glutamate (iGluRs)
mediating excitatory neuronal signaling in the mammalian CNS
is crucially involved in both, learning and memory formation and
pathological mechanisms leading to excitotoxic neuronal damage
in diverse neurological diseases1. Because mutations within sub-
units are associated with a number of diseases of the nervous
system, these receptors are of interest as a major class of targets
for novel drugs. The mammalian iGluR family includes three
major subtypes represented by several subunits: AMPA (α-
amino-3-hydroxyl-5-methyl-4-isoxazolepropionic acid; GluA1-
4), kainate (GluK1-5) and NMDA (N-methyl-D-aspartate;
GluN1, GluN2A-D, and GluN3A-B) receptors. Crystallographic
and Cryo-EM studies in recent years have provided detailed
structural information of these membrane-spanning iGluRs
(overview in refs. 2,3). They are tetrameric complexes composed
of homologous subunits. Each subunit has a conserved modular
design and is composed of an extracellular N-terminus (NTD), an
extracellular ligand-binding domain (LBD), an intracellular C-
terminus (CTD), three transmembrane domains (M1, M3, and
M4), and one pore loop (M2)3. The latter inserts into the
membrane from the intracellular side and forms together with the
M3 segment the channel pore4. The modular architecture of
iGluRs suggests that they have descended from a common
ancestral prokaryotic receptor. Notably the complex domain
architecture of all eukaryotic iGluRs is partially conserved in a
simple bacterial iGluR from Synechocystis (called GluR0)5, indi-
cating an origin of all eukaryotic iGluRs before the
prokaryote–eukaryote dichotomy occurred. However, although a
structural overall similarity between the LBD and the trans-
membrane domains composed of the segments M1–M3 has been
proposed5,6, the bacterial GluR0 greatly differs from its eukaryotic
counterparts and lacks the NTD, M4, and CTD. Interestingly, the
LBD and channel pore domain of iGluRs are structurally related
to other bacterial proteins, i.e., the substrate binding proteins
(SBP) and potassium (K+)-channels, respectively7–9. For both
bacterial protein families, crystallization has yielded detailed
structures with related function and highlighted the idea that
SBPs and K+-channels are functional homologous to the LBD
and the M1–M3 segment of iGluRs, respectively. Therefore an
evolutionary link between these bacterial protein families and the
GluR0 was proposed which might arise by the insertion of an
inverted K+-channel pore between the SBP domains leading to
the formation of a modular prototype of potassium-speciﬁc
channels (i.e., GluR0)5 (see for illustration Fig. 1a). Prokaryotic
SBPs facilitate chemotaxis and substrate uptake of a large variety
of small molecules and ions by binding their ligands with high
speciﬁcity and afﬁnity. Interestingly, SBPs share also a common
ligand binding mechanism with the LBD of iGluRs consisting of
two-lobed domains (S1 and S2) connected by a hinge forming a
clamshell-like structure7. Ligand binding takes place at the
interface between the two domains, inducing a domain closure.
This conformational change functions as the key element in the
transition of ligand recognition and ion channel gating in
iGluRs10,11. K+-channels are selective for potassium ions and
comprise a large family of ion channels. All K+-channels share
the same core topology and tetrameric structure and differ only in
the presence or absence of additional transmembrane helices and
of additional non-membrane domains. The basic channel-
forming core is composed of two transmembrane helices (TM1
and TM2; called S5 and S6 in voltage-dependent potassium (Kv)
channels) with low sequence similarity between the different
K+-channels. The TM1 and TM2 domains are separated by a
pore loop (P-loop), which inserts into the membrane from the
extracellular side and contains a conserved “TXXTVGYG” sig-
nature sequence of all K+-channel selectivity ﬁlters12,13. However,
although K+-channels and the pore-forming core domain of
iGluRs share a common architecture, the K+-channel selectivity
ﬁlter is not conserved and the pore-forming core domain of the
K+-channelshows an inverted orientation in the membrane.
Nevertheless, the apparent sequence and structural similarities of
the different domains led to the hypothesis that the GluR0 is a
modular composition of an inverted bacterial K+-channel and a
SBP and represents the precursor of mammalian iGluRs8. How-
ever, a functional compatibility between the pore structure of a
K+-channel and the LBD of an iGluR could yet not been
demonstrated, although several studies tried without success to
fuse the LBD of iGluRs with diverse K+-channels. Based on these
negative results the hypothesis of a compatible architecture of
iGluR and K+-channel pores was rejected14,15. Here, we revisit
the possibility of fusing the membrane-spanning domain of the
small viral KcvATCV-1 potassium channel to the glutamate-
binding LBD of the AMPA iGluR subunit (GluA1) for creating a
functional glutamate-gated potassium channel. It has been shown
that small viral K+-channels are because of their structural sim-
plicity, functional robustness and the absence of any coevolution
with cellular proteins most suitable as building blocks in synthetic
channels where they maintain their conductive properties in the
presence of attached regulatory domains16–18. With this
approach, we can show that the fusion of the LBD of GluA1 to the
minimal K+-channel pore of KcvATCV-1 generates a truly
glutamate-gated K+-channel. Collectively this provides experi-
mental support for the hypothesis of a phylogenetic link between
iGluRs and K+-channels. It also implies a conserved activation
mechanism of the pore region of iGluRs and ancestral viral
K+-channels, which is gated by mechanical coupling to the LBD.
Results
Design of glutamate-gated GluA1/KcvATCV-1 chimeras. To
investigate a putative functional compatibility of the pore struc-
ture of K+-channels and mammalian iGluRs, we substituted the
channel forming transmembrane domain region of the AMPA
GluA1 by a minimal K+-channel of viruses named KcvATCV-1 for
K+-channel from chlorella virus (see for illustration Fig. 1a).
These viral channel proteins have the structural and functional
hallmarks of pro- and eukaryotic K+-channels19, but are com-
posed of only 82 amino acids and likely constitute the minimal
unit of a functional K+-channel pore module. A structural
overlay of a homology model of the KcvATCV-1 (see Methods) on
the crystal structure of the transmembrane domains of the
GluA2 subunit (Protein Database entry 3KG220); in combination
with published sequence alignments (see refs. 21–23) revealed that
the TM2 helix of the KcvATCV-1 is about eight amino acids shorter
than the M3 and TM2 domain of canonical iGluR and
K+-channels, respectively. Remarkably, the last amino acids of
the C-terminal helix of TM2 in KcvATCV-1 overlap with the N-
terminal sequence of the highly conserved SYTANLAAF motif in
iGluR linking the M3 to the LBD (Fig. 1b24). Inspired by this
homology we generated an initial AMPA GluA1 receptor chimera
(GluATCVshort; Fig. 1c) by inserting the KcvATCV-1 pore at
position 538 and 634 of the GluA1. In this construct the TM2
helix of the viral protein was extended by the rest of the C-
terminal part of the SYTANLAAF motif to match the total M3
length of iGluRs. To avoid glutamate-mediated channel desensi-
tization, we used a construct containing the desensitization atte-
nuated mutant L479Y in the LBD of the GluA125,26 in all
following experiments.
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When we analyzed GluATCVshort by two-electrode voltage
clamping in Xenopus laevis oocytes, we could not elicit any
currents in response to 1 mM glutamate (Glu). Remarkably,
compared to control oocytes, we observed a large leakage current
(Ileak) in the range of 0.9 ± 0.3 µA in the absence of the agonist
which could be efﬁciently blocked by the speciﬁc K+-channel
blocker Ba2+ (93.5 ± 1.6%; n= 5; Fig. 1d; Table 1)27, but not with
the speciﬁc competitive glutamate antagonist CNQX (6-cyano-7-
nitroquinoxaline-2,3-dione). From these data we reasoned that
the pore domain of the KcvATCV-1 converted the GluATCVshort
construct into a K+-channel-like behavior, which, however, could
not be gated by external Glu. Since the M3-LBD linker is a crucial
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Fig. 1 Design of KcvATCV-1/GluA1chimeras. a The cartoon depicting the topology of a subunit of the KcvATCV-1 (blue), GluA1 (brown), and the chimera
GluATCV harboring the membrane-spanning domain of the KcvATCV-1. Amino-terminal domain (NTD), ligand-binding domain (LBD), C- terminal domain
(CTD), pore helix (P), transmembrane domains (TM respectively M in case of GluA1), substrate-binding-protein (SBP, dark brown). Permeant cations are
indicated. b Structural overlay TM of KcvATCV-1 and GluA2. TM1 and pore helix as well as M1 and M2 of GluA2 are transparent. TM of KcvATCV-1 (TM2) and
GluA2 (M3) are in full color. Helices were superimposed by aligning main-chain atoms of TM2 segments from KcvATCV-1 model (see Methods) on crystal
structure of M3 domain of GluA2 subunit (Protein Database entry 3KG220) (side view). Backbones and residues of subunits are illustrated in ribbon
representations (blue: KcvATCV-1; brown: GluA2) within iGluRs conserved SYTANLAAF region (green) and position of G77 and F78 of KcvATCV-1 (red).
c Design of GluATCV constructs. Partial sequence alignment of GluA1, GluA2, and different GluATCV constructs. Illustration of amino acid cutting sites of
different GluA1/KcvATCV-1 chimeras (GluATCV). Chimeras harboring different lengths of the SYTANLAAF motif (green) with corresponding residue
numbering of mature subunits (KcvATCV-1 blue; GluA1 brown) are indicated. GluATCVlong (linker length+ 13 aa); GluATCVshort (linker length+ 8 aa),
and GluATCV (no linker). Residues found at cutting sites and within the SYTANLAAF motif are highlighted. Secondary structure elements found are
illustrated above the sequence. d Functional characterization of chimeric GluATCV constructs. Representative whole-cell currents of glutamate (Glu)
responses and Ba2+ inhibition of GluA1/KcvATCV-1 chimeras upon heterologous expression in Xenopus oocytes recorded at −70mV membrane potential.
Oocytes expressing GluATCVshort and GluATCV were superfused with the indicated concentration of glutamate in the absence and presence of 500 µM
Ba2+. Current traces illustrating inhibitory effects of Ba2+ in both chimera. Note that K+-speciﬁc blocker Ba2+ inhibits both glutamate-induced currents
elicited from GluATCV and leak current in GluATCVshort expressing oocytes. Black dotted line indicates Ba2+ insensitive leakage current. Bars show
timepoint and duration of the application. Gray dotted line and arrows indicate glutamate induced current (IGlu) and barium blockable current (IBa)
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element in iGluR gating10, we generated two additional constructs
with variable lengths of the TM2 helix (Fig. 1c). Strikingly,
although the new construct with a 13 amino acid deletion
including the SYTANLAAF motif (GluATCV; Fig. 1c) showed
again a high leakage current (0.6 ± 0.2 µA; Table 1), it responded
in a robust manner to Glu. Application of the ligand
elicited currents with 0.4 ± 0.3 µA in amplitude (Fig. 1d;
n= 10). In contrast, the construct containing the whole
SYTANLAAF motif (GluATCVlong; Fig. 1c) behaved similar to
the initial GluATCVshort construct and remained insensitive to
Glu application. Both, the initial leakage and the Glu-evoked
currents of the GluATCV could be blocked by Ba2+ (Fig. 1d).
Quantitative analysis of the Ba2+-sensitive Glu-induced response
and the resting leakage current (IGlu/IBa) revealed that 36.4 ± 4.6%
(n= 5) of the total Ba2+-sensitive currents in the GluATCV
construct could be speciﬁcally induced by Glu-application
(Table 1). The results of these experiments indicate that the
substitution of the pore-forming transmembrane domains of the
GluA1 by a minimal viral K+-channel resulted in a Glu-gated K
+-channel with a relatively high spontaneous activity in the
resting state.
Increase of glutamate efﬁcacy. It is known that KcvATCV-1 has a
high intrinsic open probability (Po)19, suggesting that the high
leakage current of the GluATCV construct might be due to a high
intrinsic spontaneous activity of the KcvATCV-1 pore domain. To
test this hypothesis, we exploited a recent ﬁnding of the related
KcvNTS channel, where two substitutions had been shown to
greatly reduce Po28. We therefore analyzed the open probability
of the wt (wildtype) KcvATCV-1 and the corresponding double-
mutant KcvATCV* by functional reconstitution in planar lipid
bilayers. Consistent with the data of the related KcvNTS, sub-
stitution of G77 to S and F78 to L caused also in the KcvATCV-1 a
signiﬁcant reduction in the Po from 0.83 ± 0.11 to 0.14 ± 0.01 in
the KcvATCV* mutant at −60 mV (Fig. 2a, b; p < 0.001; unpaired
two-side t-test; 95% conﬁdence interval=−0.8497 to −0.569; n
= 4) without altering single channel conductance (79 ± 6.1 and
81 ± 4.0 pS for the GluATCV and GluATCV*, respectively;
Fig. 2b). In the next step we tested whether these mutations alter
the ratio IGlu/IBa in the GluATCV construct. The data in Fig. 2c
show that the double mutant G614S/F615L in the GluATCV*
(* for low intrinsic spontaneous activity) generates indeed the
expected effect. GluATCV* generated currents with a drastic
reduced leakage component (Ileak= 0.2 µA ± 0.1; n= 5) and a
concomitant increase in the amplitude of the Glu-inducible
current (Fig. 2c, d; IGlu= 0.7 ± 0.2 µA; n= 5). Again, both, the
glutamate-induced and the leakage currents could be efﬁciently
blocked by Ba2+ (Fig. 2c) underscoring that both currents are
generated by the GluATCV* channel. Obviously, by reducing the
spontaneous activity of the pore domain in the GluATCV* con-
struct, indicated by the 2-fold decrease in the Ba2+-sensitive
leakage currents (Fig. 2d), the contribution of the Glu-induced
current to the total current increased by a factor of 2 (GluATCV*
68.2 ± 5.2% vs. GluATCV 36.4 ± 4.6%; Fig. 2d; Table 1; p=
0.0017; unpaired two-side t-test; 95% conﬁdence interval=
−47.74 to −15.94; n= 5). Remarkably, although the fractional
contribution of the Ba2+-sensitive leakage and Glu-mediated
currents were inversely affected in the GluATCV and the
GluATCV* constructs, the maximal Ba2+-sensitive currents were
not different (GluATCV 1.0 ± 0.3 µA vs. GluATCV* 0.8 ± 0.2 µA).
The results of these experiments suggest that the overall expres-
sion and activity of the two constructs were similar and that a
high intrinsic spontaneous activity of the channel pore hampers
the efﬁciency of the Glu-mediated channel opening in our
GluATCV constructs.
Pharmacological characterization of the GluATCV*. For a ﬁrst
pharmacological characterization of the GluATCV*, we deter-
mined glutamate dose–response curves and calculated the
respective EC50 (half maximal effective concentration) values for
the parental GluA1 and GluATCV*. Remarkably, neither the
resulting Glu-induced current traces nor the EC50 values of the
GluATCV* were distinguishable from those of the GluA1
receptor (Fig. 3a, b). Both showed desensitization attenuated Glu-
currents with similar EC50 values (5.8 ± 1.2 and 4.0 ± 0.4 µM for
the GluATCV* and GluA1, respectively; p= 0.2; n= 8). Similarly,
inhibition curves with the competitive AMPA antagonist CNQX
revealed an IC50 (half maximal inhibitory concentration) value
comparable to wt GluA1 (4.4 ± 0.9 and 2.2 ± 0.1 µM for the
GluATCV* and GluA1, respectively; p= 0.1; unpaired two-side
t-test; 95% conﬁdence interval −5.045 to 0.6263; n= 5; Fig. 3c).
These data show that the insertion of a KcvATCV-1* channel pore
did neither affect (i) the amplitude of the current responses nor
(ii) the apparent agonist and antagonist-afﬁnity. In summary, the
results of these experiments show that the GluATCV* pharma-
cology is similar to the native GluA1 channel.
In further experiments, we examined the ion selectivity of
GluATCV*. Since the GluA1 channel exhibits no selectivity for
K+ over Na+29, we tested whether insertion of the KcvATCV-1*
channel converts the unspeciﬁc GluA1 monovalent cation
channel into a speciﬁc K+-selective channel by ion substitution.
Analysis of Glu-induced current/voltage (I/V)-curves in bath
solutions in which K+ was replaced by Na+ showed that the
GluATCV* caused, different to GluA1, a shift of the reversal
voltage as a function of the extracellular K+ concentration: the
shift in reversal voltage of GluATCV* can be ﬁtted with a Nernst
equation providing a mean shift of 59.3 ± 4.9 for a 10-fold
increase in [K+]o. In the same experiments GluA1 only responds
with a shift of 3.9 ± 4.7 to a 10-fold change in [K+]o (Fig. 3d).
This shift of the reversal voltage conﬁrms a high selectivity for K+
over Na+ in the GluATCV* channel. The P(Na+)/P(K+) ratio
can be calculated by the Goldman–Hodgkin–Katz equation under
bi-ionic conditions and is with 0.04 ± 0.01 similar to that of
KcvATCV-127, but signiﬁcantly different from that of the
nonselective GluA1 channel (P(Na+)/P(K+) of 0. 87 ± 0.02; p <
0.05; see also refs. 30,31). Collectively our results show that the
Table 1 Leakage currents and fractional Ba2+-sensitivity of control and GluATCVshort, GluATCV and GluATCV* expressing
oocytes
Uninjected GluATCVshort GluATCV GluATCV*
Initial leakage current [µA] 0.1 ± 0.06 0.9 ± 0.3 0.6 ± 0.2 0.2 ± 0.1
Ba2+-block of the leakage current [%] <10% 93.5 ± 1.6 84.4 ± 2.3 32.9 ± 10.8***
Glutamate-induced fraction of the Ba2+-block [%] n.d. n.d. 36.4 ± 4.6 68.2 ± 5.2**
Note that the fractional contribution of the Ba2+-sensitive leakage current to the overall leakage and of the Glu-induced current to the total Ba2+-sensitive current are highly signiﬁcantly different
between GluATCV and GluATCV* expressing oocytes (**, p = 0.0017; unpaired two-side t-test; ***, p < 0.0001; unpaired two-side t-test; n = 5). n.d. not detectable
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GluATCV* chimera functions as a K+-selective, glutamate-gated
channel. It combines both, the characteristics of ligand recogni-
tion of the GluA1 iGluR and the selectivity of the KcvATCV-1.
Design of a minimal glutamate-gated potassium channel. To
investigate the minimal structural requirements for a functional
Glu-gated Kcv channel we successively truncated GluA1 domains.
First, we examined whether an N-terminally truncated
GluATCV* construct that lacks amino acids 19–395 of the
mature subunit (GluATCV*ΔNTD, Fig. 4a) forms functional
receptors in X. laevis oocytes. Figure 4a shows that receptors
composed of the NTD-deleted GluATCV*ΔNTD subunit still
displayed robust agonist responses. In the presence of saturating
glutamate concentrations, the Imax values were similar to those of
the full-length GluATCV* receptor (Fig. 4a; Imax= 1.0 ± 0.26 µA;
p= 0.8; one-way ANOVA with turkey correction; n= 5), indi-
cating that the N-terminal domain is neither essential for
GluATCV assembly nor for function. Next, a C-terminal trun-
cated GluATCV*ΔNTD subunit was generated by deleting residues
downstream of V784 including transmembrane domain M4 and
the whole C-terminal domain (GluATCV*ΔNTD ΔM4; Fig. 4a).
Although 55% of the initial GluATCV construct is deleted in the
GluATCV*ΔNTD ΔM4, we observed desensitization-attenuated
currents with similar Imax values after applying Glu at saturating
concentrations (Fig. 4a, b). Since these currents are comparable to
those generated by the GluA1 and the full-length GluATCV*
receptors (Fig. 4b), we reasoned that neither the NTD nor the C-
terminal domain (including M4) of the GluA1 in the GluATCV*
construct are required for receptor assembly, membrane inser-
tion, and functional expression. This prompted us to determine
the apparent glutamate afﬁnities of the truncated constructs. The
analysis shows that the Glu-afﬁnities of GluATCV* and
GluATCV*ΔNTD ΔM4 receptors were 3-fold different with EC50
values of 5.8 ± 1.2 vs. 20.8 ± 2.6 µM, respectively (p < 0.001;
unpaired two-side t-test; 95% conﬁdence interval −0.02056 to
−0.009614; n= 4; Fig. 4c). The afﬁnity in the GluATCV*ΔNTD
receptor on the other hand was similar to that of the full-length
channel (5.8 ± 1.0 µM). Based on current models of iGluR acti-
vation, we assume from these data that anchoring of the LBD to
the M4 may be essential for high-afﬁnity Glu-binding to
GluATCV receptors. To test the importance of LBD–TM inter-
actions for receptor stabilization, we identiﬁed in the GluA2 (PDB
entry 3KG2) based GluATCV homology model (Methods) two
amino acids in the N-terminal part of TM1 (V152) and at
the very C-terminus of the LBD (N407) (Fig. 4a inset). The side
chains of these amino acids are directed into the center of
the subunit towards an intra-subunit cavity. We measured that
the Cα atoms are separated by less than 5 Å. This implies that a
disulﬁde bond between the LBD and the TMs could be formed for
stabilizing LBD–TM interactions. To test this hypothesis the two
residues were substituted by cysteine. The resulting
GluATCV*ΔNTD ΔM4 V152C/N407C construct and the GluATCV*
and GluATCV*ΔNTD ΔM4 receptors were expressed in oocytes
and the Glu-current response recorded in the absence and pre-
sence of dithiothreitol (DTT), which reduces disulﬁde bonds
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Fig. 2 Increase of Glu-gating efﬁciency in GluATCV by TM2 point mutations. a Single channel recordings of the KcvATCV-1 and KcvATCv-1*. Currents of
KcvATCV-1 and KcvATCV-1* (mutated at aa positions (G77S, F78L)) were recorded at a membrane potential of +60 and −60mV upon reconstitution in
planar lipid bilayer (see Methods). Note the difference of the open probability in the characteristic single channel ﬂuctuations of the two K+ channels.
b Analysis of the open probability and single channel conductance of KcvATCV-1 and KcvATCV-1*. Plot of the open probabilities (Po) and single channel
conductance (pS) of the wt and mutant KcvATCV-1 channel by calculating the time of occupancy of the open state (O) and the closed state (C) from 4
independent 1 min recordings at +60 and −60mV (p < 0.001; unpaired two-side t-test; n= 4). c Overlay of representative recordings of glutamate (Glu)
responses and Ba2+ inhibition at GluATCV (red) and GluATCV* (black). Arrow illustrates the differences in the ratio of the inhibition of the glutamate-
induced currents and the resting leakage by the K+-speciﬁc blocker Ba2+ in GluATCV and GluATCV* expressing oocytes. Dotted line indicates the Ba2+
insensitive leakage current. d Fractional contribution of the Ba2+-sensitive leakage- and of Glu-induced currents in GluATCV constructs. Percentage of the
Glu-induced currents of the total Ba2+-sensitive current in GluATCV* is highly signiﬁcant increased compared to the GluATCV (68.2 ± 5.2% vs. 36.4 ±
4.6%, respectively; p= 0.0017; unpaired two-side t-test; 95% conﬁdence interval=−47.74 to −15.94; n= 5)
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between cysteine residues32. The resulting Glu-dose–response
curves in the absence of DTT were indistinguishable from those
of the M4 containing GluATCV* receptors (GluATCV* and
GluATCV*ΔNTD). Remarkably, after DTT treatment, only the
EC50 value of the GluATCV*ΔNTD ΔM4 V152C/N407C receptor
showed a signiﬁcant 2-fold decrease in apparent Glu-afﬁnity
(from 5.9 ± 0.4 to 10.5 ± 0.7 µM; p= 0.001, unpaired two-side t-
test; 95% conﬁdence interval −0.006532 to −0.002572; n= 6)
whereas the EC50 values of the GluATCV* and the
GluATCV*ΔNTD ΔM4 receptors were not affected by DTT
(Fig. 4c). At the same time, the maximal inducible currents of all
constructs tested were not signiﬁcantly changed by the addition
of DTT. These data are consistent with the idea that the pair of
cysteines, which were introduced in GluATCV*ΔNTD ΔM4 V152C/
N407C receptors, is able to form a disulﬁde bond. Breaking of this
bond by DTT resulted in a decrease in apparent Glu-afﬁnity. The
results of these measurements suggest that stabilizing of LBD–TM
interactions via a linker (exempliﬁed at position 152 and 407)
contributes to ligand afﬁnity of GluATCV receptors, in an
otherwise complete functional state of the receptor.
Discussion
Our data demonstrate that a naive coupling of the LBD of the
mammalian GluA1 subunit from the ionotropic glutamate
receptor family (iGluR) with the viral potassium channel
KcvATCV-1 generates a K+-selective, glutamate-gated receptor
channel. This functional compatibility of the LBD of an iGluR
with the minimal pore domain of a K+-channel underscores a
modular architecture with a conserved activation mechanism
within the two families and highlight their phylogenetic link. A
functional coupling of the two orthogonal domains also provides
a tool to understand the most basic mechanical interactions
between ligand recognition and channel gating irrespective of co-
evolutionary constrains. Ultimately it may foster the design of
new K+-selective biosensors for speciﬁc analyte recognition.
For many years it has been suggested that the pore modules of
K+-channels and iGluRs share a similar architecture and that
they might have a common evolutionary ancestor8,9. This idea of
a direct phylogenetic link has been supported by similarities in
amino-acid sequences and homologies in structural details of the
respective pore domains13,33–36. However, an experimental
afﬁrmation of this hypothesis by demonstrating a functional
convertibility of an iGluR and a K+-channel was not provided so
far. In contrast, data from several studies argue against a com-
patible architecture of iGluR and K+-pores14,15. Here, we can
show that a chimeric construct between the LBD of the mam-
malian GluA1 and the viral potassium channel KcvATCV-1 func-
tions efﬁciently as a K+-selective, glutamate-gated ion channel
with the speciﬁc characteristics of ligand recognition of the iGluR
and the ion selectivity of the K+-channel. This result strongly
supports the idea of a modular design of iGluRs in which the pore
originated from an ancestral K+-channel. Furthermore, the
results shed some interesting light on a common molecular
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mechanism for the activation of P-loop channels in general. In
particular, our initial rationale to use a minimal viral K+-channel
for linking an iGluR LBD was, that the helical segment of the
inner TM2 in KcvATCV-1 is too short to interfere with the
endogenous iGluR channel gate (SYTANLAAF-motif gate;
overview in refs. 10,35,37). Therefore, we assumed that including
the SYTANLAAF motif of the iGluR in our constructs might
render the viral K+ channel sensitive to LBD-mediated gating.
We ﬁnd however that this motif is not essential for Glu-mediated
K+-channel gating; it can be substituted by an endogenous, so far
not anticipated K+-viral gate.
Glutamate-gated channel opening is thought to be mediated
via an iris-like conformational change in the TMs38 by pulling the
M3 pore-forming helices away from the central pore axis upon
glutamate-binding1,2,4,20. This proposed mechanism is compar-
able with K+-channel gating39,40. This simple mechanical model,
which is supported by molecular dynamics simulations and
combined functional and computational studies41,42, predicts that
the closed-to-open free energy of the channel should be related to
the tension within the LBD-M3 linker; the channel open prob-
ability should be determined by the LBD-M3 linker length.
However, based on recent cryo-EM studies in the GluA238 this
view of a simple action of the linkers as a rigid mechanical lever
has been challenged. Here, based on the 2-fold symmetrical
arrangement of the LBDs, the S2-M3 linkers connecting the LBDs
to the pseudo-4-fold symmetrical channel form two conforma-
tional distinct diagonal pairs and contribute geometrically and
energetically different to channel opening38. The differential
P
**
GluATCV*ΔNTD ΔM4
GluATCV*
GluA1
b c
a
100 μM Glu
0
GluATCV* ΔNTD ΔNTD ΔM4 ΔNTD ΔM4 N407C
V152C
0.5
1
1.5
I m
a
x 
G
lu
 (μ
A)
Extracellular
Intracellular
N
N N
C
N
n.s.
TM
1
TM
2
TM
1
TM
2
TM
1
TM
2
TM
1
TM
2
M
4
M
4
4,7Å
TM1
TM2
P PP
CTD
C
CTD
C
C152 C407
C152
C407
I p
er
 I m
a
x 
(%
)
Glutamate (mM)
ΔNTD ΔM4 N470C V152C
+DTT
ΔNTD ΔM4 N470C V152C
ΔNTD ΔM4
ΔNTD ΔM4
+DTT
GluATCV*
GluATCV*
+DTT
2
10–5 10–4 10–3 10–2 10–1 100
0
50
100
0,5 μA
1 μA
60 s
Fig. 4 Design of minimal Glu-gated viral potassium channels. a Schematic drawings and functional expression of the deletion and mutant constructs used.
Cartoons depicting the NTD- and the M4 truncated versions and the cysteines mutated (indicated by red stars); Inset: Point mutations in the LBD (N407C)
and TM1 segment (V152C) thought to form a disulﬁde-bridge are highlighted in red based on our homology model against 3KG2. Numbers correspond to
amino acid positions in the mature protein. Imax currents of each mutant, with and without DTT in the case of the cysteine double mutant, are shown (p=
0.8; one-way ANOVA with turkey correction; n= 4–10). b Overlay of representative whole cell current traces of Glu-gated GluATCV*, GluATCV*ΔNTD
ΔM4, and GluA1. The respective traces in response to application of 100 µM glutamate (Glu) are shown in magenta, black, and orange, respectively. Note
that the overall shape of the glutamate-induced whole cell currents is similar between the constructs. c Glu dose–response curves of GluATCV* (black
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contribution of the linker pairs results in an inherent asymmetric
state of the M3 helices, which is similar to a recently described
pairwise asymmetric dimer of dimers state proposed by a kink in
the inner TM2 domain in viral potassium channels28. Thus,
although the gating hinges in the TM2 of potassium channels and
in the M3 of iGluRs seem to be different and structural unique,
we think that the 2-fold changes in the M3 of iGluRs mediated by
LBD dimers and the pairwise asymmetric state in the TM2 during
viral K+-channel gating are converted to channel opening; this
mechanism seems to be conserved in tetrameric P-loop ion
channels. This may sufﬁciently explain the functionality of our
minimal construct by a phylogenetically conserved, pairwise
adopted asymmetric channel conﬁguration during channel
opening below the principal rotational symmetry of the pore.
The present data provide implications for our understanding of
iGluR assembly. For several years it was thought that the tetra-
meric assembly of iGluRs is mediated by inter-subunit interfaces
including the NTD, LBD and the TMD segments (overview in
ref. 3). This simple view has been questioned by experimental
data. By using deletion constructs it has been shown that the
NTDs do not play the important role in iGluR assembly43,44
which was previously anticipated. The importance of the trans-
membrane domains in oligomerization remains still con-
troversial. As an additional player interactions of the TMs with
the M4 segment have been implicated as important for subunit
assembly43–48. The present data show that constructs, in which
M4 was deleted, are still able to assemble into functional
glutamate-gated channels. This argues against a critical role of the
M4 for proper receptor assembly. This ﬁnding is consistent with
data obtained for the NMDAR45,46,49, where deletion of the M4
domain did not affect receptor assembly and surface expression.
Together, these ﬁndings are also in line with the functional
subunit structure of a bacterial iGluR (i.e., GluR0 from Syne-
chocystis), which contains only two TM segments (M1 and M3)
and no NTD.
It is worth mentioning that a construct, in which the M4
domain was deleted, displayed a decreased apparent glutamate
afﬁnity. This indicates a role of the S2-M4 linker or of the M4
domain in transducing agonist efﬁcacy to channel opening. As
already mentioned, changes in the LBD layer are transmitted to
ion channel opening by means of the LBD–TM linkers. Although
the most important changes seem to occur in the M3-S2 linkers, it
has been shown in the GluA2 structure that changes are also
observed in S2-M4 linkers38. This is consistent with either a
contribution of the S2-M4 linkers and/or the M4 segment in
gating kinetics or a simple stabilization of the LBD via a rigid TM
anchor. We ﬁnd that breaking and forming of a disulﬁde bond
between two cysteines of the C-Terminus of S2 and the TMs
affected the apparent glutamate afﬁnity, indicating that anchoring
of the LBDs may affect M3-S2 linker tension.
Finally, our results are consistent with a modular architecture
of iGluRs and a phylogenetic link between these proteins and
K+-channels. Chiu and colleagues50 proposed that the core
function of iGluRs occurred before animals and plants separated
from a common albeit unknown prokaryotic ancestor. The pre-
sent data support the view that a key stage in the evolution of
iGluRs was presumably the insertion of an inverted potassium
channel pore domain between the two parts (S1 and S2) of a
bacterial SBP. Despite a low sequence identity, SBPs are structural
homologous to the LBD of iGluRs and share a common ligand
binding mechanism. Thus, it can be assumed that the fusion of
the two proteins may have occurred in prokaryotes. This is
reﬂected in the K+-selective GluR0 channel lacking the NTD and
M4 domains. Indeed, homology modeling and simulation studies
of GluR0 supports a degree of common fold and functional
similarity between the pore-forming region in GluR0 and the
prokaryotic K+-channel KcsA51. In this study, we report the
functional characterization of GluATCV, where a eukaryotic
iGluR LBD was functionally linked with success to a K+-channel
pore. Interestingly this was achieved by using a viral potassium
channel, e.g., a channel which is from a structural point of view
very simple and evolutionary ancient52. Collectively these data
support the idea of an ancient phylogenetic link between iGluRs
and K+-channels. The present data furthermore underscore that
a primitive channel with poor control on gating can acquire
sophisticated ligand-mediated regulation via a naive coupling
with an orthogonal LBD. This proof of concept ﬁnding makes it
likely that ligand gated channels occurred as a result of a singular
evolutionary step. Following this line of thought we also predict
that synthetic GluATCV channels can now offer an excellent
experimental system for understanding structure/function cor-
relates in complex glutamate receptors. In a learning-by-building
approach the synthetic channels can now be engineered in such a
way that they exhibit the functional behavior of complex gluta-
mate receptors. In this way it will be possible to understand in an
unbiased manner the basic structural interactions between the
sensing and the pore unit, which are crucial for the function of
complex glutamate receptors.
Methods
Materials. CNQX (6-cyano-7-nitroquinoxaline-2,3-dione) was purchased from
Tocris (Biotrend, Cologne, Germany), all further chemicals were purchased from
Sigma (Taufkirchen, Germany). Restriction enzymes, Phusion polymerase and T4
ligase were purchased from Thermo Fisher (Waltham, USA).
DNA constructs, oocyte expression and TEVC. Rattus norvegicus GluA1 gluta-
mate receptor carrying the mutation L479Y (Genebank ID EDM04494.1) provided
by R. Sprengel (MPI for medical research, Heidelberg) and the K+ channel from
chlorella virus KcvATCV-1 (GeneID 5470584) were subcloned into the expression
Vector pEXP5-NT/TOPO by using the pEXP5-CT/TOPO ® TA Expression Kit of
Invitrogen. The GluATCV constructs were generated by replacing the nucleotide
sequence encoding amino acids 538–629 (GluATCVlong), 634 (GluATCV short)
and 642 (GluATCV) of the mature GluA1 by the KcvATCV-1 sequence with the use
of XhoI and NheI. The GluATCVΔNTD and GluATCVΔM4 constructs were gen-
erated by excising the nucleotide sequence encoding amino acids 19–394 and
upstream of 784 of the mature GluA1 by deletion PCR, respectively. All constructs
were conﬁrmed by DNA sequencing (Seqlab, Göttingen, Germany).
cRNAs were synthesized by using the AmpliCap-Max™ T7 High Yield Message
Maker Kit of Cellscript (Madison, Wi, USA) with the plasmid linearized by AatII.
X. laevis oocytes were used for two electrode voltage-clamp (TEVC)
electrophysiology as previously described53. Oozytes were surgically obtained from
female X. laevis after anesthesia with 0.1% Tricaine in water under the approval of
the Technical University of Darmstadt (Agreement V54-19c20/15 DA8/Anz. 20).
After the harvest, oocytes were incubated for 1 h in 0.8 mg collagenase in frog
ringer [96 mM NaCl, 2 mM KCl, 1 mM CaCl2,1 mM MgCl2, and 5 mM HEPES
(pH 7.4 with NaOH)]53. After the treatment and a washing step with Ca2+ free
ringer [96 mM NaCl, 2 mM KCl,1 mM MgCl2, and 5 mM HEPES (pH 7.4 with
NaOH)] oocytes of stage V and VI were selected and defolliculated by pipetting
with a burned glass-Pasteur-pipette. For electrophysiological analysis, oocytes were
injected with 50 ng in a volume of 50 nl of the respective construct. After injection
the oocytes were incubated in ND-96 solution (96 mM NaCl, 2 mM KCl, 1 mM
CaCl2, 1 mM MgCl2, 5 mM HEPES, pH 7.4 with NaOH) at 18 °C for 3–5 days until
the electrophysiological measurements. The TEVC recordings were performed at
room temperature with an Axoclamp 900A ampliﬁer, digitized with a Digidata
1550A at 5 kHz after low-pass ﬁltering at 200 Hz and recorded with Clampex 10.7
(Molecular Devices, San Jose, USA). For recording the microelectrodes were ﬁlled
with 3M KCl (resistance 0.8–2.8 MΩ in external solution) and the oocytes were
clamped at −70 mV. The external solution was a modiﬁed ringer solution
containing 100 mM KCl; 10 mM HEPES; 1.8 mM CaCl2; 1 mMMgCl2 (pH 7.4 with
KOH) alone or containing agonist. L-glutamate, CNQX, and Ba2+ were applied to
the oocytes in external solution at the given concentrations. Dose–response curves
of CNQX were determined in the presence of 5 µM glutamate (corresponding to
the EC50 value) and normalized to the current in the absence of CNQX. Whole-cell
current–voltage relationships of saturating glutamate-induced currents were
recorded in ramps from −140 mV to 140 mV with 14 mV/100 ms in 2 s in
solutions with different concentrations of potassium (substituted by sodium) and
corrected by the current values obtained in the absence of glutamate. For
treatments with DTT, oocytes were superfused with 2 mM DTT for 100 s before
applying glutamate in the presence of 2 mM DTT as described by Lynagh et al.53.
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Protein production and Bilayer measurements. The proteins of KcvATCV-1
and KcvATCV-1* were produced in an in vitro transcription reaction with the
MembraneMax™ HN Protein Expression Kit in presence of nanolipoproteins in
accordance with manufacturer’s instruction54. The reaction was puriﬁed by His-
tags fused to the nanolipoproteins over a HisPur NI-NTA spin column (Thermo
Scientiﬁc, Waltham, USA) after manufacturer protocol and eluted with 250 mM
imidazole. For bilayer experiments a dilution of 1:5000 in 250 mM imidazole was
used.
Bilayer experiments were performed in a vertical planar lipid bilayer chamber54
and channel activity was measured with an eOne Ampliﬁer from Elements s.r.l.,
(Cesena, Italy) under symmetric conditions with solution containing 100 mM
potassium chloride with 10 mM HEPES pH 7.4. Planar lipid bilayers were formed
over a hole of ca. 100 µm in a 20 µm Teﬂon foil, which was pretreated with 1%
hexadecane solution in n-hexane. Bilayers were made from 1,2-diphytanosyl-sn-
glycero-3-phosphocholine (DPhPC, from Avanti Polar Lipids, Alabaster, Alabama)
diluted at 15 mg/ml in n-pentane with the folding technique55. The phospholipid
solution was therefore added as monolayer on the measure solution and after
evaporation of the solvent a bilayer was folded by raising the solutions in the
chambers. After formation of a bilayer, the electrical activity of the empty
membrane was monitored at a voltage of ±100 mV to exclude contaminations or
lipid pores. Only when the bilayer was stable and electrically silent a small amount
(1 µl) of protein (KcvATCV-1 or KcvATCV-1*) in nanodiscs diluted 1:5000 in 250 mM
imidazole was added to the trans chamber near the membrane with a Hamilton
syringe. After insertion of an active channel the voltage protocol was applied again
and the resulting currents were recorded with Ag/AgCl electrodes. The data were
digitized at 5 kHz after lowpass ﬁltering at 2.5 kHz.
Analysis. Current responses to glutamate were plotted against glutamate con-
centration and ﬁt with non-linear regression with variable slope in Prism version
7.00 (GraphPad Software Inc., La Jolla, USA) as described56. The proportion of
glutamate sensitive current to complete barium sensitive current was calculated by
IGlu/IBa. Permeability ratio was calculated by the shift of the reversal potential
with the Goldman–Hodgkin–Katz equation under bi-ionic conditions
PNaþ
PKþ
¼ exp ΔErev  FRT
 
27. The amplitude was measured with KielPatch and also
the open probability in bilayer measurements was analyzed by the build in
Hinkley-jump-detector of KielPatch (http://www.zbm.uni-kiel.de/aghansen/
software.html). Values given represent means ± SEM. Statistical signiﬁcance was
determined at the p < 0.05 (*), p < 0.01 (**), and p < 0.001 (***) levels using a
Student’s two-tailed, unpaired two-side t-test or ANOVA (in case of more groups)
and a Tukey post-hoc analysis (Prism 7.00). All data are shown as boxplots with a
center line representing the median; box limits are the upper and lower quartiles;
whiskers representing min and max.
Structure model. The homology model of KcvATCV-1 was made with Swiss-model
against the KirBac1.157, the homology model of GluATCV* ΔM4 was built against
the GluA2 structure 3KG2 also with swiss-model and the structure overlays was
built with UCSF Chimera58 and the MatchMaker plugin with default values.
Distance of C152/C407 mutants was measured in this homology model of
GluATCV* ΔM4 by the chimera distance tool between Cα atoms.
Reporting summary. Further information on experimental design is available in
the Nature Research Reporting Summary linked to this article.
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